Literature DB >> 3135073

Iron chelating drugs.

G J Kontoghiorghes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3135073      PMCID： PMC2546205          DOI： 10.1136/bmj.296.6637.1672-c

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  6 in total

1.  Dose response studies using desferrioxamine and orally active chelators in a mouse model.

Authors:  G J Kontoghiorghes
Journal:  Scand J Haematol       Date:  1986-07

2.  Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.

Authors:  G J Kontoghiorghes
Journal:  Mol Pharmacol       Date:  1986-12       Impact factor: 4.436

3.  1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload.

Authors:  G J Kontoghiorghes; M A Aldouri; L Sheppard; A V Hoffbrand
Journal:  Lancet       Date:  1987-06-06       Impact factor: 79.321

4.  Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.

Authors:  G J Kontoghiorghes; L Sheppard; A V Hoffbrand; J Charalambous; J Tikerpae; M J Pippard
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

5.  Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits.

Authors:  G J Kontoghiorghes; A V Hoffbrand
Journal:  Br J Haematol       Date:  1986-04       Impact factor: 6.998

6.  Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

Authors:  G J Kontoghiorghes; M A Aldouri; A V Hoffbrand; J Barr; B Wonke; T Kourouclaris; L Sheppard
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.